Suchergebnisse - (Subject:"Adalimumab")

PubPharm (12.462)

61

Efficacy and safety of adalimumab in pediatric patients with Crohn's disease : A systematic review and meta-analysis

enthalten in: European journal of clinical pharmacology | 2024

von Chen, B. | Zou, Z. | Zhang, X. | +2

62

Prospective Observational Evaluation of the Time-Dependency of Adalimumab Immunogenicity and Drug Concentration in Ulcerative Colitis Patients : the POETIC II Study

enthalten in: Journal of Crohn's & colitis | 2024

von Harnik, S. | Abitbol, C. | Haj Natour, O. | +15

CommentIn: J Crohns Colitis. 2023 Oct 17;:. - PMID 37847799

63

Expression of Circulating let-7e and miR-126 May Predict Clinical Remission in Patients With Crohn's Disease Treated With Anti-TNF-α Biologics

enthalten in: Inflammatory bowel diseases | 2024

von Guglielmi, G. | Crucitta, S. | Bertani, L. | +7

64

Adalimumab : A 'Maillon Faible' in the Treatment of Ulcerative Colitis?

enthalten in: Journal of Crohn's & colitis | 2024

von Roblin, X. | Paul, S.

CommentOn: J Crohns Colitis. 2024 Mar 1;18(3):341-348. - PMID 37691574

65

Formation and clearance of TNF-TNF inhibitor complexes during TNF inhibitor treatment

enthalten in: British journal of pharmacology | 2024

von Berkhout, L. | I'Ami, M. | Kruithof, S. | +11

66

Quantifying the Effect of Methotrexate on Adalimumab Response in Psoriasis by Pharmacokinetic-Pharmacodynamic Modeling

enthalten in: The Journal of investigative dermatology | 2024

von van Huizen, A. | Bank, P. | van der Kraaij, G. | +12

67

Relationship Between Adalimumab Concentrations, Antidrug Antibodies, and Disease Activity in Rheumatoid Arthritis : A Cross-Sectional Observational Study

enthalten in: The Journal of rheumatology | 2024

von Stamp, L. | Keating, P. | Frampton, C. | +5

68

Comparison between super-responders and non-super-responders in psoriasis under adalimumab treatment : a real-life cohort study on the effectiveness and drug survival over one-year

enthalten in: The Journal of dermatological treatment | 2024

von Liu, Y. | Hu, K. | Jian, L. | +3

69

Response Types and Factors Associated with Response Types to Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis from Two Randomized Clinical Trials

enthalten in: Dermatology and therapy | 2024

von Egeberg, A. | Conrad, C. | Gorecki, P. | +4

70

Adalimumab exhibits superiority over etanercept in terms of a numerically higher response rate and equivalent adverse events : A real-world finding

enthalten in: Immunity, inflammation and disease | 2024

von Yu, Z. | Gao, L. | Zang, Y. | +3